Tokyo University
53
4
4
29
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
9.4%
5 terminated/withdrawn out of 53 trials
85.3%
-1.2% vs industry average
8%
4 trials in Phase 3/4
10%
3 of 29 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (53)
Impact of Nutrition, Sleep, and Physical Activity on Intellectual Function and Muscle Mass in Older Adults
Role: lead
MSA-01 in Multiple System Atrophy
Role: lead
Endoscopic Ultrasound-guided Rendezvous Versus Precut Papillotomy
Role: collaborator
Integrating Services for Noncommunicable Diseases in Continuum of Care for Mothers and Children
Role: lead
Pilot Cluster RCT of an Indirect Contact Mental Health Literacy Program for 5th-Grade Students
Role: lead
Scenario-Driven Virtual Reality Game for Dementia Education Program
Role: collaborator
Education Program for Enhancing Healthcare Students' Attitudes Toward People Living With Dementia
Role: collaborator
Enhancing Healthcare Students' Attitudes Toward Dementia Care Through Virtual Reality Education
Role: collaborator
The Medical Management in Patients Exposed to Weapons of Mass Destruction
Role: collaborator
Teacher-led MHL Education in Japanese Preteens
Role: lead
Encapsulation-oriented vs. Timing-oriented Strategies for Necrotizing Pancreatitis
Role: lead
Liver Injury After COVID-19 Vaccination
Role: collaborator
The Overall Survival of Patients With Unresectable HCC in Real-life
Role: collaborator
Early-stage Ovarian Clear Cell Carcinoma (OCCC) Patients at Risk of Recurrence
Role: collaborator
WONDER-02 Trial: Plastic Stent vs. Lumen-apposing Metal Stent for Pancreatic Pseudocysts
Role: lead
Immediate Necrosectomy vs. Step-up Approach for Walled-off Necrosis
Role: lead
Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer
Role: collaborator
Safe Motherhood Promotion and Newborn Survival
Role: collaborator
Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)
Role: collaborator
Optimal Treatment for Spinal Cord Injury Associated With Cervical Canal Stenosis (OSCIS) Study
Role: lead